[ Price : $8.95]
FDA issues a draft guidance on testing and labeling medical devices for safety in the magnetic resonance environment.[ Price : $8.95]
FDA issues a final guidance on developing drugs to treat bacterial vaginosis.[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled E8(R1) General Considerations for Clinical Studies.[ Price : $8.95]
FDA extends for five years its medical device innovation collaboration with Frances Dassault Systmes.[ Price : $8.95]
FDA expands the approval for Leo Pharmas Enstilar and Taclonex to treat plaque psoriasis in patients 12 years and older.[ Price : $8.95]
Ultragenyx Pharmaceutical files an NDA for UX007 (triheptanoin) for treating long-chain fatty acid oxidation disorders.[ Price : $8.95]
CDERs Office of Prescription Drug Promotion says a CooperSurgical TV spot for ParaGard is misleading because it doesnt give risk i...[ Price : $8.95]
FDA approves Mercks Keytruda (pembrolizumab) for patients with recurrent, locally advanced or metastatic, squamous cell carcinoma ...